Global Gamma Knife Radiosurgery Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Gamma Knife Radiosurgery industry revenue is expected to be around $872.4 million in 2025 and expected to showcase growth with 7.4% CAGR between 2025 and 2034. Gamma Knife Radiosurgery holds promise in the field of healthcare due to recent technological advancements that allow for less invasive procedures for patients requiring neurosurgery. This innovative approach is gaining attention within the industry as more people become aware of and embrace these cutting edge surgical techniques. The growing prevalence of conditions globally further contributes to the demand, for Gamma Knife Radiosurgery services. The increasing number of individuals prone to brain related illnesses highlights its importance as well as the growing emphasis, on tailored medical treatments and personalized healthcare has significantly boosted its usage in current therapeutic practices.
Gamma Knife Radiosurgery is well known for its accuracy and effectiveness in targeting brain disorders using a system for stereotactic radiosurgery procedures. It is primarily used for treating malignant tumors as well, as vascular malformations and functional disorders in a non invasive manner.
Market Key Insights
The Gamma Knife Radiosurgery market is projected to grow from $812.3 million in 2024 to $1.66 billion in 2034. This represents a CAGR of 7.4%, reflecting rising demand across Brain Metastasis Treatment, Treatment of Arteriovenous Malformations (AVM), and Trigeminal Neuralgia Management.
Elekta AB, Varian Medical Systems Inc, and Brainlab AG are among the leading players in this market, shaping its competitive landscape.
U.S. and Japan are the top markets within the Gamma Knife Radiosurgery market and are expected to observe the growth CAGR of 4.8% to 7.1% between 2024 and 2030.
Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 8.5% to 10.2%.
Transition like Advancements in Radiosurgical Technology is expected to add $117 million to the Gamma Knife Radiosurgery market growth by 2030
.The Gamma Knife Radiosurgery market is set to add $846 million between 2024 and 2034, with manufacturer targeting Specialized Clinics & Cancer Research Institutes Application projected to gain a larger market share.
With
rise in brain tumor cases, and
Advancements in Technology, Gamma Knife Radiosurgery market to expand 104% between 2024 and 2034.
Opportunities in the Gamma Knife Radiosurgery
Growth Opportunities in North America and Asia Pacific
Market Dynamics and Supply Chain
Driver: Rise in Brain Tumor Cases, and Shifting Preference Towards Non-Invasive Procedures
Restraint: High Treatment Costs
Opportunity: Expanding market in developing countries and Emerging applications of the technology
Challenge: Limited Awareness and Skilled Professionals
Supply Chain Landscape
Raw Material Procurement
Equipment Manufacturing
Distribution & Sales
End-Users
Raw Material Procurement
Equipment Manufacturing
Distribution & Sales
End-Users
Use Cases of Gamma Knife Radiosurgery in Brain Metastasis Treatment & Trigeminal Neuralgia Management
Recent Developments
Gamma Knife Radiosurgery is a cutting edge innovation, in the field of medicine that involves a invasive brain surgery technique using powerful gamma rays to precisely treat brain conditions while minimizing harm to surrounding healthy tissues.